Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
PLoS Negl Trop Dis ; 12(7): e0006648, 2018 07.
Artigo em Inglês | MEDLINE | ID: mdl-30001342

RESUMO

Chandipura Virus (CHPV), a negative-stranded RNA virus belonging to the Rhabdoviridae family, has been previously reported to bring neuronal apoptosis by activating several factors leading to neurodegeneration. Following virus infection of the central nervous system, microglia, the ontogenetic and functional equivalents of macrophages in somatic tissues gets activated and starts secreting chemokines, thereby recruiting peripheral leukocytes into the brain parenchyma. In the present study, we have systemically examined the effect of CHPV on microglia and the activation of cellular signalling pathways leading to chemokine expression upon CHPV infection. Protein and mRNA expression profiles of chemokine genes revealed that CHPV infection strongly induces the expression of CXC chemokine ligand 10 (CXCL10) and CC chemokine ligand 5 (CCL5) in microglia. CHPV infection triggered the activation of signalling pathways mediated by mitogen-activated protein kinases, including p38, JNK 1 and 2, and nuclear factor κB (NF-kappaB). CHPV-induced expression of CXCL10 and CCL5 was achieved by the activation of p38 and NF-kappaB pathways. Considering the important role of inflammation in neurodegeneration, we have targeted NF-kappaB using a newly synthesised natural product nitrosporeusine analogue and showed incapability of microglial supernatant of inducing apoptosis in neurons after treatment.


Assuntos
Alcaloides/administração & dosagem , Antivirais/administração & dosagem , Doenças do Sistema Nervoso Central/tratamento farmacológico , Microglia/imunologia , NF-kappa B/imunologia , Infecções por Rhabdoviridae/imunologia , Vesiculovirus/fisiologia , Animais , Linhagem Celular , Sistema Nervoso Central/imunologia , Sistema Nervoso Central/virologia , Doenças do Sistema Nervoso Central/genética , Doenças do Sistema Nervoso Central/imunologia , Doenças do Sistema Nervoso Central/virologia , Quimiocina CCL5/genética , Quimiocina CCL5/imunologia , Quimiocina CXCL10/genética , Quimiocina CXCL10/imunologia , Humanos , Camundongos , Microglia/efeitos dos fármacos , Microglia/virologia , NF-kappa B/genética , Infecções por Rhabdoviridae/tratamento farmacológico , Infecções por Rhabdoviridae/genética , Infecções por Rhabdoviridae/virologia , Transdução de Sinais/efeitos dos fármacos , Vesiculovirus/efeitos dos fármacos , Vesiculovirus/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA